Bloomberg -- Novo Nordisk A/S’s diabetes drug liraglutide helped overweight, healthy volunteers lose significantly more weight and cut their blood pressure more than Roche Holding AG’s obesity treatment Xenical, a study found.
Bloomberg -- Novo Nordisk A/S’s diabetes drug liraglutide helped overweight, healthy volunteers lose significantly more weight and cut their blood pressure more than Roche Holding AG’s obesity treatment Xenical, a study found.
